ADME studies and preliminary safety pharmacology of LDT5, a lead compound for the treatment of benign prostatic hyperplasia

por Noël, F., Nascimento-Viana, J.B., Romeiro, L.A.S., Silva, R.O., Lemes, L.F.N., Oliveira, A.S., Giorno, T.B.S., Fernandes, P.D., Silva, C.L.M.
Publicado 2016